January 18, 2015
Maynard, MA –- CHI Scientific, Inc., an innovator in the field of cell culture, today announced the release of PrimaCell™ protocols for culturing more than 300 types of primary cells that will enable scientists to overcome the variability of experimental results derived from today’s individualized time-consuming procedures. These bench-proven protocols developed for PrimaCell? cell culture [...]
SP Industries Acquires Stability Environments, Inc.
January 16, 2015
Warminster, PA -- SP Industries, Inc. ("SP"), a leading designer and manufacturer of state-of-the-art laboratory equipment, biological drug manufacturing solutions, laboratory solutions and specialty glassware, announced today that it has acquired privately held Stability Environments, Inc. a global provider of Walk-in Environmental Rooms, Glassware Dryers, Chambers and accessory products. "Stability Environments has a well-earned reputation [...]
Dr. Martin Madaus to Retire from METTLER TOLEDO Board of Directors
January 16, 2015
COLUMBUS, Ohio -- Mettler-Toledo International Inc. (NYSE:MTD) announced today that Dr. Martin D. Madaus will be retiring as a director of the Board, effective May 7, 2015, to fully devote time to his new role as Chairman and Chief Executive Officer of Ortho-Clinical Diagnostics. Robert F. Spoerry, Chairman of the Board, stated, "We sincerely thank [...]
Affinity Life Sciences to Produce Lyophilized Chem-Bio Assays for SRC Acumen
January 16, 2015
Amherst, NH -- Affinity Life Sciences, Inc. and SRC Acumen, LLC are announcing the continued production of freeze-dried qPCR and toxin assays. As part of this agreement, Affinity Life Sciences will manufacture these products exclusively for SRC Acumen. SRC Acumen’s assays are unique in their ability to provide near real-time, interferent resistant, one-step identification of [...]
Agilent Technologies Names Alacris Theranostics as Certified Provider of Target Enrichment Services
January 16, 2015
SANTA CLARA, Calif.-- Technologies Inc. (NYSE: A) today announced it has named Alacris Theranostics, a Berlin-based company active in the area of next-generation sequencing (NGS)-driven personalized medicine, as an Agilent Certified Service Provider for target enrichment. Agilent certifies select laboratories that leverage the company's market-leading technologies to provide analysis services of the highest quality. Hands-on [...]
January 16, 2015
Palo Alto, California -- PREMIER Biosoft today announced that eminent protein biochemist, John Wiktorowicz, PhD, has joined the company’s scientific advisory board. "We are very pleased to welcome Dr. Wiktorowicz to our scientific advisory board and look forward to his guidance as we deploy informatics to serving proteomics research," said Arun Apte, Chief Executive Officer [...]
BiOptix Announces Appointment of Ken Dickerson as Vice President of Sales
January 15, 2015
Boulder, Colorado -– BiOptix is pleased to announce the appointment of Ken Dickerson as Vice President of Sales. Ken joins the company from ACEA Biosciences where he was National Sales Director. Ken has also held sales management positions at Roche and GE Healthcare over his 20 year career. “I am excited to have Ken join [...]
PURDUE ACQUIRES PROTEA’S LAESI® TECHNOLOGY
January 15, 2015
MORGANTOWN, W.V.-- Protea Biosciences Group, Inc. (OTCQB:PRGB) ("Protea") announced today that Purdue University has acquired Protea's LAESI® DP-1000 Instrument System for direct molecular analysis. The system will be used in Purdue's College of Agriculture, the Department of Botany and Plant Pathology, for the molecular imaging of herbicide active ingredients and other related compounds to optimize [...]
January 15, 2015
ALAMEDA, Calif. -– LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the commercial release of VarElect, a powerful, yet easy-to-use application for prioritizing gene variants resulting from next generation sequencing (“NGS”) experiments. VarElect rapidly prioritizes gene variants according to their potential association to a disease or phenotype of interest, and can aid in [...]
Nabsys and Ariana Pharma Collaborate to Identify DNA Structural Variants Linked to Targeted Cancers
January 15, 2015
PROVIDENCE, R.I. and PARIS -- Nabsys, Inc., a life sciences company pioneering semiconductor-based tools for human genomic analysis in oncology, and Ariana Pharmaceuticals SA, a developer of innovative clinical data analysis and diagnostic solutions for the healthcare sector, today announced a collaboration that aims to identify sets of DNA structural variants linked to prostate and [...]
